Neil Brewis

3PUBLICATIONS
51CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 12, 2024
IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy.

Charlotte J Imianowski, Paula Kuo, Sarah K Whiteside

|Dec 13, 2023
M9657 Is a Bispecific Tumor-Targeted Anti-CD137 Agonist That Induces MSLN-Dependent Antitumor Immunity without Liver Inflammation.

Chunxiao Xu, Xueyuan Zhou, Lindsay Webb

|Nov 07, 2022
A Phase 1 First-in-Human Study of FS118, a Tetravalent Bispecific Antibody Targeting LAG-3 and PD-L1 in Patients with Advanced Cancer and PD-L1 Resistance.

Timothy A Yap, Patricia M LoRusso, Deborah J Wong

Pageof 1

Frequent Collaborators

2 joint publications

Michelle Morrow

1 joint publications

Timothy A Yap

1 joint publications

Patricia M LoRusso

1 joint publications

Deborah J Wong